Cargando…
CEACAM6 serves as a biomarker for leptomeningeal metastasis in lung adenocarcinoma
BACKGROUND AND AIMS: Diagnosis of leptomeningeal metastasis (LM) is challenging. In our previous study, CEACAM6 mRNA was found to be highly expressed in the circulating tumor cells of cerebrospinal fluid (CSF) from patients with lung adenocarcinoma with LM (LUAD‐LM). The aim of this study was to ide...
Autores principales: | Wang, Xueying, Tang, Xuemei, Gu, Jiahui, Sun, Ziwei, Yang, Shengrui, Mu, Yuan, Guan, Ming, Chen, Kun, Liu, Wei, Ruan, Haoyu, Xu, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972070/ https://www.ncbi.nlm.nih.gov/pubmed/36082960 http://dx.doi.org/10.1002/cam4.5221 |
Ejemplares similares
-
Comprehensive RNA analysis of CSF reveals a role for CEACAM6 in lung cancer leptomeningeal metastases
por: Li, Yingmei, et al.
Publicado: (2021) -
CEACAM6 is a determinant of pancreatic adenocarcinoma cellular invasiveness
por: Duxbury, M S, et al.
Publicado: (2004) -
A Rare Case of Metastasis of Gastric Adenocarcinoma to the Leptomeninges
por: Doshi, Krishna, et al.
Publicado: (2023) -
METTL7B serves as a prognostic biomarker and promotes metastasis of lung adenocarcinoma cells
por: Li, Rong, et al.
Publicado: (2022) -
Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers
por: Blumenthal, Rosalyn D, et al.
Publicado: (2007)